Crossmark Global Holdings, Inc. Coherus Bio Sciences, Inc. Transaction History

Crossmark Global Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 10, 2022	SELL	$15.81 - $18.99 $579,594 - $696,173	-36,660 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$12.68 - $17.79 $464,848 - $652,181	36,660 New	36,660 $589,000
Q3 2021 Oct 13, 2021	SELL	$12.68 - $17.79 $464,848 - $652,181	-36,660 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$12.95 - $15.41 $1,942 - $2,311	150 Added 0.41%	36,660 $507,000
Q1 2021 Apr 15, 2021	BUY	$14.42 - $21.39 $576 - $855	40 Added 0.11%	36,510 $533,000
Q4 2020 Jan 14, 2021	BUY	$16.56 - $18.94 $603,943 - $690,741	36,470 New	36,470 $634,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.